{
    "Trade/Device Name(s)": [
        "QMS Everolimus Assay System",
        "Thermo Scientific QMS Everolimus Reagents",
        "Thermo Scientific QMS Everolimus Calibrators",
        "Thermo Scientific QMS Everolimus Controls"
    ],
    "Submitter Information": "Microgenics Corporation (Thermo Fisher Scientific, Clinical Diagnostics Division)",
    "510(k) Number": "K100144",
    "Predicate Device Reference 510(k) Number(s)": [
        "K034069"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NRP",
        "OUF",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "February 3, 2011",
    "Summary Letter Received Date": "February 4, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3840"
    ],
    "Regulation Name(s)": [
        "Sirolimus test system"
    ],
    "Analyte Class(es)": [
        "transplant",
        "toxicology"
    ],
    "Analyte(s)": [
        "Everolimus"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Particle agglutination assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Homogeneous assay",
        "Optical measurement at 700nm"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for QMS Everolimus Assay System using particle agglutination for quantitative measurement of everolimus in whole blood to aid management of kidney transplant patients.",
    "Indications for Use Summary": "Quantitative determination of everolimus in human whole blood to aid in management of kidney transplant patients receiving Everolimus therapy; intended for clinical laboratory use on automated clinical chemistry analyzers.",
    "fda_folder": "Toxicology"
}